ArticleJournal of clinical imaging science2025
Comparison of the quality of prostate images from different diffusion-weighted imaging sequences: Single-shot echo-planar, reduced field-of-view, readout-segmented multi-shot.
Article in Journal of clinical imaging science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Accelerating prostate MRI: a practical review of modern acquisition strategies.Abdominal radiology (New York) · 2026Review
- Comparative evaluation of zoomed and parallel diffusion-weighted imaging: A phantom study.Journal of clinical imaging science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The objectives of the study are to compare the prostate image quality (IQ) obtained with single-shot echo-planar diffusion-weighted imaging (ss-DWI), reduced field-of-view diffusion-weighted imaging (rf-DWI), and readout-segmented multi-shot diffusion-weighted imaging (rs-DWI), along with their diagnostic efficacy for clinically significant prostate cancer (csPCa), to optimize prostate magnetic resonance diffusion-weighted imaging sequences. Material and Methods: We have analyzed prostate images from 72 patients who underwent ss-DWI, rs-DWI, and rf-DWI magnetic resonance imaging (MRI) scans from March 2023 to September 2024. Two radiologists qualitatively evaluated the IQ of three diffusion-weighted imaging (DWI) sequences and corresponding apparent diffusion coefficient (ADC) images as well as Prostate Imaging Reporting and Data System Version 2.1 (PI-RADS v2.1) category of prostate nodules and measured the anterior-posterior diameter and right-left (RL) diameters of the prostate on both types of images and ADC values of prostate nodules. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated. Qualitative and quantitative differences across DWI techniques were statistically compared. Results: The rf-DWI images demonstrated optimal clarity, minimal distortion/artifacts, and the highest CNR and lowest SNR. The RL diameter of the prostate measured on T2-weighted images was larger than those on ss-DWI images, and the RL diameter measured on ss-DWI images was smaller than those measured on rf-DWI images ( Conclusion: Compared to ss-DWI and rs-DWI, the rf-DWI sequence demonstrates optimal IQ and quantitative parameters with the optimum diagnostic performance for csPCa, making it the best choice for prostate scans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.